BridgeMD
Tests treatment safety and results for Glaucoma
Official title Phase 2/Phase 3 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
ClinicalTrials.gov ID: NCT07075718
What this study is testing
What is Gen 2 Travoprost Intracameral Implant?
Gen 2 Travoprost Intracameral Implant is an investigational medicine, given as an once-daily, being studied as a potential treatment for glaucoma.
Also referred to as Gen 2 Travoprost Intraocular Implant.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
- Phase 3: a large, late-stage study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Diagnosis of open-angle glaucoma or ocular hypertension in the study eye
You likely can't join if
- Prior incisional glaucoma surgery in the study eye
- Prior argon laser trabeculoplasty (ALT) in the study eye
- Prior minimally invasive glaucoma (MIGS) surgery in the study eye
The study team makes the final eligibility decision.
Where it's taking place
- Grand Junction, Colorado, United States
- Oklahoma City, Oklahoma, United States
- El Paso, Texas, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Grand Junction, Colorado, United States; Oklahoma City, Oklahoma, United States; El Paso, Texas, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.